voxalatamab (JNJ-63898081) / J&J 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  voxalatamab (JNJ-63898081) / J&J
    Trial completion, Trial completion date, Metastases:  A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors (clinicaltrials.gov) -  Dec 3, 2021   
    P1,  N=40, Completed, 
    ADA resulting in decreased exposure occurred in the majority of pts treated SC. Active, not recruiting --> Completed | Trial completion date: Nov 2022 --> Sep 2021
  • ||||||||||  voxalatamab (JNJ-63898081) / J&J
    Enrollment closed, Enrollment change, Metastases:  A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors (clinicaltrials.gov) -  Jul 21, 2021   
    P1,  N=40, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial completion date: Nov 2022 --> Sep 2021 Recruiting --> Active, not recruiting | N=90 --> 40
  • ||||||||||  voxalatamab (JNJ-63898081) / J&J
    Trial completion date, Metastases:  A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors (clinicaltrials.gov) -  Jan 29, 2021   
    P1,  N=90, Recruiting, 
    Recruiting --> Active, not recruiting | N=90 --> 40 Trial completion date: Oct 2021 --> Nov 2022